- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Doximity Inc (DOCS)
The Doximity share price today is 20.59, view NYSE DOCS stock exchange data. Track the latest Doximity share price with real-time updates on DOCS stock performance including market cap, day range, 52-week range and dividend yield. Access DOCS charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.38
21.14
52 wk Range
17.15
76.51
DOCS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.3821.14
52 wk Range
17.1576.51
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DOCS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
25.15
Upside
+22.15%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
10 Buy
13 Hold
0 Sell
Ratings:
23 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 25.15
(+22.15% Upside)
Doximity Inc SWOT Analysis
Digital Health Giant | Doximity dominates the healthcare professional network space, connecting over 80% of U.S. physicians and offering marketing, hiring, and telehealth solutions. |
Financial Crossroads | Despite impressive margins and growth, Doximity faces valuation scrutiny. Analysts project revenue of $619-631 million for FY2026, with an average price target of $67.40. |
Innovation Frontie | Explore Doximity's strategic acquisitions and AI investments, potentially driving long-term growth and efficiency in the evolving digital health landscape. |
Market Dynamics | Delve into how shifting pharma advertising trends and potential healthcare reforms could reshape Doximity's revenue streams and competitive positioning. |
Doximity Inc Earnings Call Summary for Q4/2026
- Doximity Q4 2026 EPS of $0.26 missed forecast of $0.28 by 7.14%; revenue beat expectations at $145.4M vs. $144.07M, up 5% YoY.
- Stock plunged 11.57% to $26.36 in aftermarket trading as increased AI compute costs compressed margins despite strong 90% gross profit margin.
- Free cash flow rose 11% YoY to $107M; adjusted EBITDA reached $66M with 45% margin, demonstrating solid operational performance.
- Management emphasized strategic AI investments as critical for competitive edge, though near-term margin pressure expected to continue.
- Key risks include ongoing AI infrastructure costs, digital pharma market volatility, and macroeconomic uncertainties affecting customer spending.
Last Updated: 14-05-2026, 03:46 am
Read Full TranscriptEarnings
Latest Release
13-05-2026
EPS / Forecast
0.26 / 0.28
Revenue / Forecast
145.4M / 144.07M
Compare DOCS to Peers and Sector
Metrics to compare | DOCS | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipDOCSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.2x | 13.2x | −0.5x | |
PEG Ratio | −1.64 | 0.03 | 0.00 | |
Price/Book | 4.0x | 1.0x | 2.6x | |
Price / LTM Sales | 5.8x | 1.1x | 3.0x | |
Upside (Analyst Target) | 16.6% | 35.5% | 58.7% | |
Fair Value Upside | Unlock | 45.4% | 10.3% | Unlock |
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Doximity (DOCS) Share Price Today?
The Doximity share price today is 20.59.
What is the current Doximity (DOCS) share price and day range?
As of 07-06-2026, the Doximity share price is 20.59, with a previous close of 20.70. The share price has ranged from 20.38 to 21.14 today, while the 52-week range spans from 17.15 to 76.51.
What Is the Doximity Market Cap?
As of today, Doximity market cap is 3.77B.
What Is the Doximity (DOCS) Share Price Target?
The average 12-month share price target for Doximity is 25.15, with a high estimate of 42 and a low estimate of 18. 10 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +22.15% Upside potential.
What Is Doximity's Earnings Per Share (TTM)?
The Doximity EPS (TTM) is 0.98.
When Is the Next Doximity Earnings Date?
Doximity will release its next earnings report on 11-08-2026.
From a Technical Analysis Perspective, Is DOCS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Doximity Trade On?
Doximity is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Doximity?
The stock symbol for Doximity is "DOCS."
How Many Times Has Doximity Stock Split?
Doximity has split 0 times.
How Many Employees Does Doximity Have?
Doximity has 880 employees.
What Is the DOCS Premarket Price?
DOCS's last pre-market stock price is 20.78. The pre-market share volume is 1,940.00, and the stock has changed by 0.08, or 0.39%.
What Is the DOCS After Hours Price?
DOCS's last after hours stock price is 20.50, the stock has changed by -0.09, or -0.44%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.